BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 16716198)

  • 1. Transgenic rescue of erythroid 5-aminolevulinate synthase-deficient mice results in the formation of ring sideroblasts and siderocytes.
    Nakajima O; Okano S; Harada H; Kusaka T; Gao X; Hosoya T; Suzuki N; Takahashi S; Yamamoto M
    Genes Cells; 2006 Jun; 11(6):685-700. PubMed ID: 16716198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heme deficiency in erythroid lineage causes differentiation arrest and cytoplasmic iron overload.
    Nakajima O; Takahashi S; Harigae H; Furuyama K; Hayashi N; Sassa S; Yamamoto M
    EMBO J; 1999 Nov; 18(22):6282-9. PubMed ID: 10562540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models for X-linked sideroblastic anemia.
    Yamamoto M; Nakajima O
    Int J Hematol; 2000 Aug; 72(2):157-64. PubMed ID: 11039663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and Molecular Characterization of Human Ring Sideroblasts: a Key Role of Ferrous Iron in Terminal Erythroid Differentiation and Ring Sideroblast Formation.
    Saito K; Fujiwara T; Hatta S; Morita M; Ono K; Suzuki C; Fukuhara N; Onishi Y; Nakamura Y; Kawamata S; Shimizu R; Yamamoto M; Harigae H
    Mol Cell Biol; 2019 Apr; 39(7):. PubMed ID: 30670569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of iron supply in the regulation of 5-aminolevulinate synthase mRNA levels in murine erythroleukemia cells.
    Fuchs O; Ponka P
    Neoplasma; 1996; 43(1):31-6. PubMed ID: 8843957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular regulation of 5-aminolevulinate synthase. Diseases related to heme biosynthesis.
    May BK; Bhasker CR; Bawden MJ; Cox TC
    Mol Biol Med; 1990 Oct; 7(5):405-21. PubMed ID: 2095458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythroid 5-aminolevulinate synthase and X-linked sideroblastic anemia.
    Ferreira GC
    J Fla Med Assoc; 1993 Jul; 80(7):481-3. PubMed ID: 8089650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial iron metabolism and sideroblastic anemia.
    Sheftel AD; Richardson DR; Prchal J; Ponka P
    Acta Haematol; 2009; 122(2-3):120-33. PubMed ID: 19907149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple mechanisms for hereditary sideroblastic anemia.
    Furuyama K; Sassa S
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):5-10. PubMed ID: 11929048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine.
    Kucerova J; Horvathova M; Mojzikova R; Belohlavkova P; Cermak J; Divoky V
    Acta Haematol; 2011; 125(4):193-7. PubMed ID: 21252495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Aminolevulinate synthase in sideroblastic anemias: mRNA and enzyme activity levels in bone marrow cells.
    Bottomley SS; Healy HM; Brandenburg MA; May BK
    Am J Hematol; 1992 Oct; 41(2):76-83. PubMed ID: 1415186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388-to-Ser substitution in erythroid 5-aminolevulinate synthase.
    Cox TC; Bottomley SS; Wiley JS; Bawden MJ; Matthews CS; May BK
    N Engl J Med; 1994 Mar; 330(10):675-9. PubMed ID: 8107717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-linked sideroblastic anaemia due to ALAS₂ mutations in the Netherlands: a disease in disguise.
    Donker AE; Raymakers RA; Nieuwenhuis HK; Coenen MJ; Janssen MC; MacKenzie MA; Brons PP; Swinkels DW
    Neth J Med; 2014 May; 72(4):210-7. PubMed ID: 24829177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational control of erythroid delta-aminolevulinate synthase in immature human erythroid cells by heme.
    Smith SJ; Cox TM
    Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):103-14. PubMed ID: 9074795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia.
    Fujiwara T; Harigae H
    Free Radic Biol Med; 2019 Mar; 133():179-185. PubMed ID: 30098397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active site of 5-aminolevulinate synthase resides at the subunit interface. Evidence from in vivo heterodimer formation.
    Tan D; Ferreira GC
    Biochemistry; 1996 Jul; 35(27):8934-41. PubMed ID: 8688429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient heme and globin synthesis in embryonic stem cells lacking the erythroid-specific delta-aminolevulinate synthase gene.
    Harigae H; Suwabe N; Weinstock PH; Nagai M; Fujita H; Yamamoto M; Sassa S
    Blood; 1998 Feb; 91(3):798-805. PubMed ID: 9446639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a cell model of X-linked sideroblastic anemia using genome editing.
    Kaneko K; Kubota Y; Nomura K; Hayashimoto H; Chida T; Yoshino N; Wayama M; Ogasawara K; Nakamura Y; Tooyama I; Furuyama K
    Exp Hematol; 2018 Sep; 65():57-68.e2. PubMed ID: 29908199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
    Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
    J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent progress in iron metabolism and iron-related anemia].
    Harigae H
    Rinsho Byori; 2010 Dec; 58(12):1211-8. PubMed ID: 21348241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.